U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06967467) titled 'Allergy Delabeling in Antibiotic Stewardship - Evaluations' on April 08.
Brief Summary: The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patients with a hematological malignancy.
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Beta Lactam Allergy in Patients With a Hematologic Malignancy
Intervention:
BEHAVIORAL: Semi-structured interview
Interviews designed to obtain information about patient reasons for enrolling or declining participation in the RENEW Intervention
BEHAVIORAL: Survey
Survey which will...